To include your compound in the COVID-19 Resource Center, submit it here.

Generon's benegrastim meets in Phase III for CIN

Generon (Shanghai) Corp. Ltd. (Shanghai, China) reported data from a Phase III trial in about 122 women with stage II-IV breast cancer patients receiving

Read the full 245 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE